证券代码：688380 证券简称：中微半导 公告编号：2024-016 中微半导体（深圳）股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中微半导体（深圳）股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开了公司第二届董事会第十三次会议及第二届监事会第十一次会议，审议通 过了《关于使用闲置自有资金进行现金管理的议案》，同意公司使用额度不超过 人民币 100,000.00 万元（含本数）的闲置自有资金进行现金管理，使用期限不超 过 12 个月，在前述额度及期限范围内，公司可以循环滚动使用。同时，公司董 事会授权管理层在上述授权额度及期限内，根据实际情况办理相关事项并签署相 关文件。 上述事项在公司董事会审批权限范围内，无需提交公司股东大会审批。公司 监事会发表了明确同意的意见。现将具体情况公告如下： 一、本次使用闲置自有资金进行现金管理的基本情况 （一）现金管理目的 为提高自有资金使用效率，在不影响公司日常经营、资金安全的前提下，合 理使用部分闲置自有资 ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY, representing a 15% year-over-year growth[22]. - The company achieved operating revenue of 713.57 million RMB in 2023, a 12.06% increase compared to the previous year[26]. - The net profit attributable to shareholders was -21.95 million RMB, a decrease of 136.99% year-on-year[26]. - The company reported a revenue of 714 million yuan for 2023, a year-on-year increase of 12.06%, but net profit turned to a loss of 21.95 million yuan due to market competition and price reductions[89]. - The company’s total assets at the end of 2023 were 3.15 billion RMB, a decrease of 6.56% from the previous year[27]. - The company’s total operating revenue for the current period is RMB 713,569,748.57, representing a year-on-year increase of 12.06%[109]. - The gross profit margin decreased to 17.04%, down by 23.88 percentage points year-on-year[109]. - The company faced a notable decline in gross profit margins, particularly in the consumer electronics sector, impacting overall profitability[110]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.50 CNY per 10 shares to all shareholders, totaling approximately 99,898,750.00 CNY based on a total share capital of 399,595,000 shares after accounting for repurchased shares[5]. - The company’s profit distribution plan has been approved by the board and requires shareholder meeting approval[5]. - The cash dividend amount for the year is 99,898,750.00 RMB, with a total dividend amount (including tax) of 114,790,989.40 RMB[192][193]. - The company plans to distribute at least 80% of profits as cash dividends when in a mature stage without major investment plans[188]. - The company has confirmed that the cash dividend policy aligns with its articles of association and shareholder resolutions[190]. Research and Development - The company is investing 200 million CNY in R&D for new technologies, focusing on advanced analog and digital chips[22]. - R&D expenditure accounted for 16.88% of operating revenue, a decrease of 2.58 percentage points compared to the previous year[24]. - The company has accumulated over 1,000 proprietary IPs, enhancing its competitive edge in chip design[79]. - The company has ongoing projects with a total expected investment of ¥1,040,000,000, with cumulative investment reaching ¥432,063,593.34[75]. - The company plans to increase R&D investment in 2024 to further enhance technology and product competitiveness[37]. Market Strategy and Expansion - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by the end of 2024[22]. - The company aims to become a leading global MCU provider, focusing on smart controller chips and expanding into industrial control, automotive electronics, and healthcare sectors[148]. - The company plans to establish multiple business units (BUs) to better understand market demands and continuously upgrade products and technologies, ensuring stable revenue growth[149]. - The company adopted a strategy of "inventory reduction, market capture, and internal improvement" to navigate the challenging semiconductor market[35]. Corporate Governance and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not violated any decision-making procedures for providing guarantees to external parties[7]. - The company emphasizes that forward-looking statements in the report do not constitute a substantive commitment to investors[6]. - The company’s governance practices comply with relevant laws and regulations, ensuring transparency and effective communication with investors[156]. - The company held two shareholder meetings during the reporting period, with all proposed resolutions passed without any rejections[159]. Operational Challenges and Risks - The company is exposed to risks from high supplier concentration and potential supply chain disruptions due to external factors[95]. - The company faces risks from fluctuations in raw material and packaging processing prices, which could adversely affect operating performance[96]. - The industry is facing challenges such as slow inventory turnover and price wars, leading to increased competition and resource fragmentation[59]. - The company has implemented strategies to manage inventory and receivables to mitigate risks associated with market demand changes[96]. Product Development and Innovation - New product development includes the launch of a low-power RISC processor, which is expected to enhance market competitiveness[22]. - The company has developed high-precision ADC products, with a 24-bit ADC achieving an effective precision of 21.5 bits, enhancing measurement accuracy[44]. - The company has launched a new generation of SGT MOS, IGBT, and CSP MOS power devices, expanding its product range and enhancing its overall solution capabilities[47]. - The company focuses on MCU as its core platform for chip design, providing a one-stop solution for smart controllers, with products ranging from 8-bit to 32-bit MCUs and various ASIC chips[41]. Employee and Management Structure - The company reported a total of 426 employees, with 139 in the parent company and 287 in major subsidiaries[183]. - The company’s employee composition includes 231 technical staff, 89 production staff, and 32 sales staff, reflecting a strong technical workforce[183]. - The average salary for R&D personnel increased to ¥389,889.91 from ¥342,395.54 in the previous year[78]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to RMB 1,403.74 million[171]. Audit and Financial Reporting - The company has received a standard unqualified audit report from Tianjian Accounting Firm[6]. - The company confirmed that the 2023 first quarter report was accurate and complete, with no fraud or significant misstatements[178]. - The company’s 2023 annual report and half-year report were confirmed to be accurate and free from fraud or significant misstatements[178]. - The company held six meetings of the Audit Committee during the reporting period, confirming the accuracy and integrity of the 2022 financial data and stating that there were no fraud or significant misstatements[177].

| | | | 一、审计报告……………………………………………………… 第 | 1—5 页 | | --- | --- | | 二、财务报表……………………………………………………… 第 | 6—13 页 | | （一）合并资产负债表…………………………………………… | 第 6 页 | | （二）母公司资产负债表………………………………………… | 第 7 页 | | （三）合并利润表………………………………………………… | 第 8 页 | | （四）母公司利润表……………………………………………… | 第 9 页 | | （五）合并现金流量表……………………………………………第 | 10 页 | | （六）母公司现金流量表…………………………………………第 | 11 页 | | （七）合并所有者权益变动表……………………………………第 | 12 页 | | （八）母公司所有者权益变动表…………………………………第 | 13 页 | | 三、财务报表附注……………………………………………… 第 | 14—86 页 | | 四、附件………………………………………………………… 第 | 87—90 页 | | ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 205,428,958.59, representing a 56.12% increase compared to CNY 131,581,560.32 in the same period last year[5]. - Net profit attributable to shareholders decreased by 33.28% to CNY 28,827,267.91 from CNY 42,951,835.26 year-on-year[5]. - The net profit after deducting non-recurring gains and losses was CNY 24,728,451.82, a significant recovery from a loss of CNY 4,628,872.17 in the previous year[6]. - The basic and diluted earnings per share were both CNY 0.07, down 36.36% from CNY 0.11 in the same quarter last year[6]. - Total operating revenue for Q1 2024 was CNY 131,581,560.32, a decrease of 35.5% compared to CNY 205,428,958.59 in Q1 2023[19]. - Net profit for Q1 2024 was CNY 28,827,267.91, down 33.4% from CNY 43,206,726.94 in Q1 2023[21]. - Other income for Q1 2024 was CNY 25,252,541.95, significantly higher than CNY 534,993.10 in Q1 2023[20]. Cash Flow - The net cash flow from operating activities improved to CNY 69,972,496.43, a turnaround from a negative cash flow of approximately CNY 110,040,488.36 in the previous year[6]. - The net cash flow from operating activities for Q1 2024 was CNY 69,972,496.43, compared to a net outflow of CNY 110,040,488.36 in Q1 2023[23]. - The net cash flow from investment activities was $7,436,760.19, a significant improvement compared to a net outflow of -$142,313,679.20 in the previous year[24]. - The cash received from other investment activities was $589,724,389.75, showing a strong investment inflow compared to the previous year[24]. - The company reported a cash net increase of $74,176,375.66, contrasting with a decrease of -$252,767,705.59 in the previous year[24]. Assets and Liabilities - The company's total assets increased by 0.94% to CNY 3,180,852,355.76 compared to CNY 3,151,080,027.72 at the end of the previous year[6]. - As of March 31, 2024, the total assets of the company amounted to RMB 3,180,852,355.76, an increase from RMB 3,151,080,027.72 as of December 31, 2023, reflecting a growth of approximately 0.94%[16]. - The company's cash and cash equivalents reached RMB 991,431,778.17, up from RMB 917,255,402.51, indicating an increase of about 8.5%[16]. - Accounts receivable decreased to RMB 118,716,087.71 from RMB 150,510,046.24, representing a decline of approximately 21.1%[16]. - The total current liabilities increased to RMB 161,640,061.16 from RMB 153,042,221.15, showing a rise of about 5.2%[17]. - The total liabilities as of Q1 2024 were CNY 183,362,665.58, compared to CNY 179,441,590.35 in Q1 2023, reflecting a slight increase[20]. - Non-current assets totaled RMB 241,496,185.01, down from RMB 249,807,609.88, indicating a decrease of approximately 3.4%[17]. Research and Development - Research and development expenses totaled CNY 24,639,854.37, a decrease of 15.63% from CNY 29,203,725.26 year-on-year, representing 11.99% of operating revenue, down from 22.19%[6]. - Research and development expenses for Q1 2024 were CNY 24,639,854.37, a decrease of 15.5% from CNY 29,203,725.26 in Q1 2023[20]. - The company plans to continue enhancing its competitive edge through ongoing research and product iteration, which contributed to the substantial increase in sales volume and gross margin[10]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,205[12]. - The total equity attributable to shareholders was CNY 2,997,489,690.18, up from CNY 2,971,638,437.37 in Q1 2023[20]. - The company has not reported any significant changes in its major shareholders or their participation in financing activities during the reporting period[14]. Operational Insights - The company experienced a significant impact on net profit due to a decline in the value of its holdings in optical-electronic stocks, affecting approximately CNY 66.78 million[10]. - The company is focusing on expanding its market presence and developing new technologies, although specific details were not provided in the content[15]. - There are no applicable reminders for investors regarding the company's operational situation during the reporting period[15]. - The company did not apply new accounting standards or interpretations for the first time in 2024[25].

中微半导体（深圳）股份有限公司 （三）任职董事会专门委员会的情况 2023 年度独立董事述职报告（吴敬） 作为中微半导体（深圳）股份有限公司（以下简称"公司"）的独立董事， 本人严格按照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司治理准则》《上 市公司独立董事管理办法》（以下简称"《独立董事管理办法》"）以及《上海 证券交易所科创板上市规则》等法律法规及相关规范性文件的要求，在 2023 年 度工作中，全面关注公司发展战略，主动了解掌握公司经营状况，积极参加公司 股东大会、董事会及各专门委员会会议，认真审议各项议案并就公司的重大事项 发表了独立意见，切实履行了独立董事的各项职责和义务，审慎行使了公司和股 东所赋予的权利，维护了全体股东的合法利益，充分发挥独立董事的作用。现将 2023 年度担任独立董事的履职情况报告如下： 一、独立董事的基本情况 （一）独立董事的个人情况 公司第二届董事会共 9 名董事，其中包括 3 名独立董事：我、华金秋及宋晓 科，占公司董事人数的三分之一。作为公司独立董事，我们均拥有良好的专业资 质及能力，选任均符合《 ...

证券代码： 688380 证券简称： 中微半导 公告编号： 2024-019 中微半导体（深圳）股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开 的第二届董事会第十三次会议和第二届监事会第十一次会议，审议通过了《关于募投 项目增加实施主体及募集资金专户的议案》，同意增加中微渝芯（重庆）电子科技有 限公司（以下简称"重庆中微"）、北京中微芯成微电子科技有限公司（以下简称 "北京中微"）和 SINGAPORE CHANGI TECHNOLOGY PTE. LTD.（以下简称 "SCT"）作为募集资金投资项目（以下称"募投项目"）"大家电和工业控制 MCU 芯 片研发及产业化项目""物联网 SoC 及模拟芯片研发及产业化项目"和"车规级芯片 研发项目"的实施主体。增加实施主体后，公司募投项目均由公司、四川中微芯成科 技有限公司（以下简称"中微芯成"）、重庆中微、北京中微和 SCT 等五个主体共同 承担，并授权公司管理层新增开设相应的募集资金专户、签署募集资金监管协议及办 理其他相关事项。 公司与本次募投项目新增实施主体之间将通过支付委托研发费、内部往来等方 式具体划转募投项目实施所需募集资金， ...

证券代码：688380 证券简称：中微半导 公告编号：2024-014 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于中微半导体（深圳）股份有限公司首次 公开发行股票注册的批复》（证监许可〔2022〕910 号），本公司由主承销商中 信证券股份有限公司采用余额包销方式，向社会公众公开发行人民币普通股（A 股）股票 6,300 万股，发行价为每股人民币 30.86 元，共计募集资金 194,418.00 万元，坐扣承销和保荐费用 10,409.26 万元（其中，不含税承销费为人民币 98,200,566.04 元，该部分属于发行费用，税款为人民币 5,892,033.96 元，该部分 不属于发行费用）后的募集资金为 184,008.74 万元，已由主承销商中信证券股份 有限公司于 2022 年 8 月 2 日汇入本公司募集资金监管账户。另减除上网发行费、 招股说明书印刷费、申报会计师费、律师费、评估费等与发行权益性证券直接相 关的新增外部费用 2,947.86 万元后，公司本次募集资金净额为 181,650.09 万元。 上述募集资金到位情况业经天健会计师事务所（特殊普通合伙）验证，并由 ...

目 录 审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表……………第 3 页 非经营性资金占用及其他关联资金往来情况的 专项审计说明 天健审〔2024〕3-264 号 中微半导体（深圳）股份有限公司全体股东： 我们接受委托，审计了中微半导体（深圳）股份有限公司（以下简称中微半 导公司）2023 年度财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负债 表，2023 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公 司所有者权益变动表，以及财务报表附注，并出具了审计报告。在此基础上，我 们审计了后附的中微半导公司管理层编制的 2023 年度《非经营性资金占用及其 他关联资金往来情况汇总表》（以下简称汇总表）。 一、对报告使用者和使用目的的限定 本报告仅供中微半导公司年度报告披露时使用，不得用作任何其他目的。我 们同意将本报告作为中微半导公司年度报告的必备文件，随同其他文件一起报送 并对外披露。 为了更好地理解中微半导公司 2023 年度非经营性资金占用及其他关联资金 往来情况，汇总表应当与已审的财务报表一并阅读。 ...

2、投资者保护能力 上年末，天健会计师事务所（特殊普通合伙）累计已计提职业风险基金 1 亿 元以上，购买的职业保险累计赔偿限额超过 1 亿元，职业风险基金计提及职业保 险购买符合财政部关于《会计师事务所职业风险基金管理办法》等文件的相关规 定。 | 起诉（仲裁 | 被诉（被仲裁 | 诉讼（仲裁）事 | | 诉讼（仲裁） | | --- | --- | --- | --- | --- | | 人） | 人） | 件 | 诉讼（仲裁）金额 | 结果 | | 投资者 | 亚太药业、天 | 年度报告 | 部分案件在诉前 调解阶段，未统 | 。天健投保 | | | 健、安信证券 | | | | | | | | 计 | 的职业保险足 | | | | | | 以覆盖赔偿金 | | | | | | 额 | | | | | | ， | | 投资者 | 罗顿发展、天健 | | 未统计 | 天健投保的职 | | | | 年度报告 | | 业保险足以覆 | | | | | | 盖赔偿金额 | | | | | | ， | | 投资者 | 东海证券、华仪 | 年度报告 | 未统计 | 天健投保的职 | | | 电气、天健 | | | 业 ...

2023 年度 公司董事会审计委员会根据《公司法》《证券法》《上市公司治理准则》《上海证 券交易所科创板股票上市规则》及中微半导体（深圳）股份有限公司（以下简称"公司"） 《公司章程》等法律法规的相关规定开展工作，在 2023 年度充分利用自身专业开展工作， 勤勉尽责，积极履行工作职责，现将公司董事会审计委员会 2023 年度履职情况汇报如 下： 报告期内，公司董事会审计委员会共召开 6 次会议，具体情况如下： | | | | 1、《关于确认公司 2022 年度审计报告及财务报表的 | | --- | --- | --- | --- | | | | 第二届董事 | 议案》； 2、《关于公司董事会审计委员会 年度履职情况 2022 | | | | 会审计委员 | 报告的议案》； | | 1 | 2023/4/14 | 会 2023 年 | 3、《关于公司 2022 年年度报告及摘要的议案》 | | | | 第一次会议 | 4、《关于公司 年度财务决算报告的议案》 2022 | | | | | 5、《关于公司 2023 年度财务预算报告的议案》 | | | | | 6、《关于预计公司 2023 年度日常关联交易的 ...